919 related articles for article (PubMed ID: 33383282)
1. Dexmedetomidine Resists Intestinal Ischemia-Reperfusion Injury by Inhibiting TLR4/MyD88/NF-κB Signaling.
Yang J; Wu Y; Xu Y; Jia J; Xi W; Deng H; Tu W
J Surg Res; 2021 Apr; 260():350-358. PubMed ID: 33383282
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine Protects Cardiomyocytes against Hypoxia/Reoxygenation Injury by Suppressing TLR4-MyD88-NF-
Gao JM; Meng XW; Zhang J; Chen WR; Xia F; Peng K; Ji FH
Biomed Res Int; 2017; 2017():1674613. PubMed ID: 29359143
[TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine protects against lung injury induced by limb ischemia-reperfusion via the TLR4/MyD88/NF-κB pathway.
Xue BB; Chen BH; Tang YN; Weng CW; Lin LN
Kaohsiung J Med Sci; 2019 Nov; 35(11):672-678. PubMed ID: 31373750
[TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine Post-Conditioning Alleviates Cerebral Ischemia-Reperfusion Injury in Rats by Inhibiting High Mobility Group Protein B1 Group (HMGB1)/Toll-Like Receptor 4 (TLR4)/Nuclear Factor kappa B (NF-κB) Signaling Pathway.
Zhai Y; Zhu Y; Liu J; Xie K; Yu J; Yu L; Deng H
Med Sci Monit; 2020 Jan; 26():e918617. PubMed ID: 31912804
[TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine preconditioning may attenuate myocardial ischemia/reperfusion injury by down-regulating the HMGB1-TLR4-MyD88-NF-кB signaling pathway.
Zhang JJ; Peng K; Zhang J; Meng XW; Ji FH
PLoS One; 2017; 12(2):e0172006. PubMed ID: 28222157
[TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine Attenuates Myocardial Injury Induced by Renal Ischemia/Reperfusion by Inhibiting the HMGB1-TLR4-MyD88-NF-κB Signaling Pathway.
Zhang B; Zhang J; Ainiwaer Y; He B; Geng Q; Lin L; Li X
Ann Clin Lab Sci; 2021 May; 51(3):376-384. PubMed ID: 34162568
[TBL] [Abstract][Full Text] [Related]
7. Effect of dexmedetomidine on kidney injury in sepsis rats through TLR4/MyD88/NF-κB/iNOS signaling pathway.
Jin YH; Li ZT; Chen H; Jiang XQ; Zhang YY; Wu F
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):5020-5025. PubMed ID: 31210339
[TBL] [Abstract][Full Text] [Related]
8. Dexmedetomidine Preconditioning Ameliorates Inflammation and Blood-Spinal Cord Barrier Damage After Spinal Cord Ischemia-Reperfusion Injury by Down-Regulation High Mobility Group Box 1-Toll-Like Receptor 4-Nuclear Factor κB Signaling Pathway.
Liu J; Zhang S; Fan X; Yuan F; Dai J; Hu J
Spine (Phila Pa 1976); 2019 Jan; 44(2):E74-E81. PubMed ID: 29975331
[TBL] [Abstract][Full Text] [Related]
9. The protective effect of Luteolin on myocardial ischemia/reperfusion (I/R) injury through TLR4/NF-κB/NLRP3 inflammasome pathway.
Zhang X; Du Q; Yang Y; Wang J; Dou S; Liu C; Duan J
Biomed Pharmacother; 2017 Jul; 91():1042-1052. PubMed ID: 28525945
[TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine Protects Rat Liver against Ischemia-Reperfusion Injury Partly by the α2A-Adrenoceptor Subtype and the Mechanism Is Associated with the TLR4/NF-κB Pathway.
Wang Y; Wu S; Yu X; Zhou S; Ge M; Chi X; Cai J
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347929
[TBL] [Abstract][Full Text] [Related]
11. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
[TBL] [Abstract][Full Text] [Related]
12. Madecassoside protects BV2 microglial cells from oxygen-glucose deprivation/reperfusion-induced injury via inhibition of the toll-like receptor 4 signaling pathway.
Luo Y; Wang C; Li WH; Liu J; He HH; Long JH; Yang J; Sui X; Wang S; You Z; Wang YA
Brain Res; 2018 Jan; 1679():144-154. PubMed ID: 29198964
[TBL] [Abstract][Full Text] [Related]
13. GSK-3β Inhibitor Induces Expression of the TLR4/MyD88/NF-κB Signaling Pathway to Protect Against Renal Ischemia-Reperfusion Injury During Rat Kidney Transplantation.
Su S; Zhang P; Zhang Q; Yin Z
Inflammation; 2019 Dec; 42(6):2105-2118. PubMed ID: 31440938
[TBL] [Abstract][Full Text] [Related]
14. Dexmedetomidine Inhibits TLR4/NF-κB Activation and Reduces Acute Kidney Injury after Orthotopic Autologous Liver Transplantation in Rats.
Yao H; Chi X; Jin Y; Wang Y; Huang P; Wu S; Xia Z; Cai J
Sci Rep; 2015 Nov; 5():16849. PubMed ID: 26585410
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol preconditioning protects hepatocytes against hepatic ischemia reperfusion injury via Toll-like receptor 4/nuclear factor-κB signaling pathway in vitro and in vivo.
He D; Guo Z; Pu JL; Zheng DF; Wei XF; Liu R; Tang CY; Wu ZJ
Int Immunopharmacol; 2016 Jun; 35():201-209. PubMed ID: 27064547
[TBL] [Abstract][Full Text] [Related]
16. Dexmedetomidine preconditioning plays a neuroprotective role and suppresses TLR4/NF-κB pathways model of cerebral ischemia reperfusion.
Wang SL; Duan L; Xia B; Liu Z; Wang Y; Wang GM
Biomed Pharmacother; 2017 Sep; 93():1337-1342. PubMed ID: 28753906
[TBL] [Abstract][Full Text] [Related]
17. Dexmedetomidine preconditioning for myocardial protection in ischaemia-reperfusion injury in rats by downregulation of the high mobility group box 1-toll-like receptor 4-nuclear factor κB signalling pathway.
Yang YF; Peng K; Liu H; Meng XW; Zhang JJ; Ji FH
Clin Exp Pharmacol Physiol; 2017 Mar; 44(3):353-361. PubMed ID: 27998004
[TBL] [Abstract][Full Text] [Related]
18. Physcion Protects Rats Against Cerebral Ischemia-Reperfusion Injury via Inhibition of TLR4/NF-kB Signaling Pathway.
Dong X; Wang L; Song G; Cai X; Wang W; Chen J; Wang G
Drug Des Devel Ther; 2021; 15():277-287. PubMed ID: 33536742
[TBL] [Abstract][Full Text] [Related]
19. Daphnetin Preconditioning Decreases Cardiac Injury and Susceptibility to Ventricular Arrhythmia following Ischaemia-Reperfusion through the TLR4/MyD88/NF-Κb Signalling Pathway.
Yang F; Jiang X; Cao H; Shuai W; Zhang L; Wang G; Quan D; Jiang X
Pharmacology; 2021; 106(7-8):369-383. PubMed ID: 33902056
[TBL] [Abstract][Full Text] [Related]
20. Dexmedetomidine-mediated protection against septic liver injury depends on TLR4/MyD88/NF-κB signaling downregulation partly via cholinergic anti-inflammatory mechanisms.
Zi SF; Li JH; Liu L; Deng C; Ao X; Chen DD; Wu SZ
Int Immunopharmacol; 2019 Nov; 76():105898. PubMed ID: 31520992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
